USANA Health Sciences (NYSE:USNA) Shares Gap Down - Here's Why

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $33.38, but opened at $31.50. USANA Health Sciences shares last traded at $34.21, with a volume of 34,045 shares.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on USNA shares. StockNews.com raised USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a report on Thursday. DA Davidson raised USANA Health Sciences to a "hold" rating in a research report on Friday.

USANA Health Sciences Stock Performance

The firm's 50-day simple moving average is $37.91 and its 200-day simple moving average is $40.25. The company has a market capitalization of $646.90 million, a price-to-earnings ratio of 11.99, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.07. The business had revenue of $200.22 million during the quarter, compared to analysts' expectations of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same quarter last year, the company earned $0.59 earnings per share. Equities research analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Insider Transactions at USANA Health Sciences

In other news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is owned by insiders.

Institutional Trading of USANA Health Sciences

A number of institutional investors and hedge funds have recently added to or reduced their stakes in USNA. Exchange Traded Concepts LLC grew its position in USANA Health Sciences by 4.4% in the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company's stock valued at $292,000 after acquiring an additional 322 shares during the period. Martingale Asset Management L P grew its holdings in shares of USANA Health Sciences by 2.1% in the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company's stock worth $634,000 after purchasing an additional 340 shares during the last quarter. KBC Group NV increased its position in shares of USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company's stock worth $40,000 after purchasing an additional 519 shares in the last quarter. Safe Harbor Fiduciary LLC bought a new position in USANA Health Sciences during the 3rd quarter valued at about $30,000. Finally, Public Sector Pension Investment Board boosted its position in USANA Health Sciences by 5.4% in the second quarter. Public Sector Pension Investment Board now owns 24,270 shares of the company's stock valued at $1,098,000 after buying an additional 1,242 shares in the last quarter. Institutional investors own 54.25% of the company's stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.